31 related articles for article (PubMed ID: 38732309)
1. Association of Serum Levels and Immunohistochemical Labelling of Des-Gamma-Carboxy-Prothrombin in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma.
Chabert S; Iesari S; Dahlqvist G; Komuta M; Baldin P; Favi E; Coubeau L
Diagnostics (Basel); 2024 Apr; 14(9):. PubMed ID: 38732309
[TBL] [Abstract][Full Text] [Related]
2. Role of protein induced by vitamin-K absence-II in transplanted patients with HCC not producing alpha-fetoprotein.
Lai Q; Ito T; Iesari S; Ikegami T; Nicolini D; Larghi Laureiro Z; Rossi M; Vivarelli M; Yoshizumi T; Hatano E; Lerut J
Liver Transpl; 2024 May; 30(5):472-483. PubMed ID: 37729520
[TBL] [Abstract][Full Text] [Related]
3. Biological response under treatment and prognostic value of protein induced by vitamin K absence or antagonist-II in a French cohort of patients with hepatocellular carcinoma.
Payancé A; Dioguardi Burgio M; Peoc'h K; Achahboun M; Albuquerque M; Devictor J; Chor H; Manceau H; Soubrane O; Durand F; Castera L; Bouattour M; Paradis V
Eur J Gastroenterol Hepatol; 2020 Oct; 32(10):1364-1372. PubMed ID: 31895908
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of PIVKA-II in hepatocellular carcinoma patients receiving curative ablation: A systematic review and meta-analysis.
Zhang D; Liu Z; Yin X; Qi X; Lu B; Liu Y; Hou J
Int J Biol Markers; 2018 Aug; 33(3):266-274. PubMed ID: 29658364
[TBL] [Abstract][Full Text] [Related]
5. Patient Selection by Tumor Markers in Liver Transplantation for Advanced Hepatocellular Carcinoma.
Lee HW; Song GW; Lee SG; Kim JM; Joh JW; Han DH; Kim SI; Kim SH; Kim DS; Cho JY; Suh KS
Liver Transpl; 2018 Sep; 24(9):1243-1251. PubMed ID: 29575509
[TBL] [Abstract][Full Text] [Related]
6. The growing impact of alpha-fetoprotein in the field of liver transplantation for hepatocellular cancer: time for a revolution.
Lai Q; Iesari S; Melandro F; Mennini G; Rossi M; Lerut J
Transl Gastroenterol Hepatol; 2017; 2():72. PubMed ID: 29034345
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of PIVKA-II After Living-donor Liver Transplantation for Hepatocellular Carcinoma.
Park MS; Lee KW; Kim H; Choi YR; Hong G; Yi NJ; Suh KS
Transplant Proc; 2017 Jun; 49(5):1109-1113. PubMed ID: 28583537
[TBL] [Abstract][Full Text] [Related]
8. Des-gamma-carboxy prothrombin in hepatocellular cancer patients waiting for liver transplant: a systematic review and meta-analysis.
Lai Q; Iesari S; Levi Sandri GB; Lerut J
Int J Biol Markers; 2017 Oct; 32(4):e370-e374. PubMed ID: 28561879
[TBL] [Abstract][Full Text] [Related]
9. Preoperative prognostic values of α-fetoprotein (AFP) and protein induced by vitamin K absence or antagonist-II (PIVKA-II) in patients with hepatocellular carcinoma for living donor liver transplantation.
Kim SH; Moon DB; Kim WJ; Kang WH; Kwon JH; Jwa EK; Cho HD; Ha SM; Chung YK; Lee SG
Hepatobiliary Surg Nutr; 2016 Dec; 5(6):461-469. PubMed ID: 28124000
[TBL] [Abstract][Full Text] [Related]
10. Des-γ-Carboxyprothrombin Plasma Level in Diagnosis of Hepatocellular Carcinoma in a Chinese Population Undergoing Surgery.
Feng X; Song P; Bie P; Jiang P; Ma K; Li X; Wang S; Wang Z; Tang W; Zheng S
Med Sci Monit; 2016 May; 22():1663-72. PubMed ID: 27187589
[TBL] [Abstract][Full Text] [Related]
11. Serologic and molecular biomarkers for recurrence of hepatocellular carcinoma after liver transplantation: A systematic review and meta-analysis.
Pommergaard HC; Burcharth J; Rosenberg J; Rasmussen A
Transplant Rev (Orlando); 2016 Jul; 30(3):171-7. PubMed ID: 27118303
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of des-γ-carboxyl prothrombin in living-donor liver transplantation for recurrent hepatocellular carcinoma.
Harimoto N; Yoshida Y; Kurihara T; Takeishi K; Itoh S; Harada N; Tsujita E; Yamashita YI; Uchiyama H; Soejima Y; Ikegami T; Yoshizumi T; Kawanaka H; Ikeda T; Shirabe K; Saeki H; Oki E; Kimura Y; Maehara Y
Transplant Proc; 2015 Apr; 47(3):703-4. PubMed ID: 25819732
[TBL] [Abstract][Full Text] [Related]
13. Des-γ-carboxyprothrombin (DCP) and NX-DCP expressions and their relationship with clinicopathological features in hepatocellular carcinoma.
Sumi A; Akiba J; Ogasawara S; Nakayama M; Nomura Y; Yasumoto M; Sanada S; Nakashima O; Abe T; Yano H
PLoS One; 2015; 10(3):e0118452. PubMed ID: 25739032
[TBL] [Abstract][Full Text] [Related]
14. Performance of PIVKA-II for early hepatocellular carcinoma diagnosis and prediction of microvascular invasion.
Poté N; Cauchy F; Albuquerque M; Voitot H; Belghiti J; Castera L; Puy H; Bedossa P; Paradis V
J Hepatol; 2015 Apr; 62(4):848-54. PubMed ID: 25450201
[TBL] [Abstract][Full Text] [Related]
15. Evaluation methods for pretransplant oncologic markers and their prognostic impacts in patient undergoing living donor liver transplantation for hepatocellular carcinoma.
Shindoh J; Sugawara Y; Nagata R; Kaneko J; Tamura S; Aoki T; Sakamoto Y; Hasegawa K; Tanaka T; Kokudo N
Transpl Int; 2014 Apr; 27(4):391-8. PubMed ID: 24472068
[TBL] [Abstract][Full Text] [Related]
16. NX-PVKA levels before and after hepatectomy of hepatocellular carcinoma as predictors of patient survival: a preliminary evaluation of an improved assay for PIVKA-II.
Nanashima A; Abo T; Taura N; Shibata H; Ichikawa T; Takagi K; Arai J; Oyama S; Nagayasu T
Anticancer Res; 2013 Jun; 33(6):2689-97. PubMed ID: 23749928
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of α-fetoprotein and des-γ-carboxy prothrombin responses in patients with hepatocellular carcinoma treated with transarterial chemoembolization.
Lee YK; Kim SU; Kim DY; Ahn SH; Lee KH; Lee DY; Han KH; Chon CY; Park JY
BMC Cancer; 2013 Jan; 13():5. PubMed ID: 23282286
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic accuracy of α-fetoprotein and des-γ-carboxy prothrombin in screening for hepatocellular carcinoma in liver transplant candidates.
Yamashiki N; Sugawara Y; Tamura S; Kaneko J; Yoshida H; Aoki T; Hasegawa K; Akahane M; Ohtomo K; Fukayama M; Koike K; Kokudo N
Hepatol Res; 2011 Dec; 41(12):1199-207. PubMed ID: 21917089
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
